Last reviewed · How we verify

NCT05622656

Dexmedetomidine Reduce Postoperative Pain of C-section

Status unknown Phase 4 Last updated 18 November 2022
What this trial tests

Phase 4 trial testing Dexmedetomidine in Pain, Postoperative in 80 participants. Status unknown.

Timeline
1 December 2022
Primary endpoint
31 March 2023
31 March 2023

Quick facts

Lead sponsorFirst People's Hospital of Chenzhou
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment80
Start date1 December 2022
Primary completion31 March 2023
Estimated completion31 March 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

First People's Hospital of Chenzhou

Who can join

Adults 18 to 50, female only, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to make sure whether the infiltration of dexmedetomidine around the uterus can reduce the pain of cesarean section surgery.Studies have shown that the use of local anesthetic infiltration around the uterus can reduce pain after cesarean section surgery.In observed group, 50ug of dexmedetomidine (volume 10ml) was infiltrated around the uterus at the end of the caesarean section, while in controled group, 10ml normal saline as placebo was infiltrated around the uterus. VASs was accessed in 2h 12h,24h,48h after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other First People's Hospital of Chenzhou trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05622656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing